Literature DB >> 25807827

Purinergic receptors in skeletal muscles in health and in muscular dystrophy.

Elżbieta Krasowska, Justyna Róg, Anthony Sinadinos, Christopher N J Young, Dariusz C Górecki, Krzysztof Zabłocki.   

Abstract

The P2 purinergic (nucleotide) receptor super-family comprises of two families of protein. The P2X, which are channel-forming ionotropic receptors and the P2Y metabotropic receptors activating G protein-mediated signalling pathways. Members of both groups have been identified in skeletal muscle cells at different stages of differentiation. It is well documented that sequential expression and down-regulation of particular P2 receptors on the surface of sarcolemma is closely associated with muscle maturation during embryogenesis and postnatal growth. P2 receptors are also involved in muscle regeneration following injury. Moreover, enhanced expression of specific purinergic receptors together with increased availability of extracellular ATP in dystrophic muscles are important elements of the dys- trophic pathophysiology considerably increasing severity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25807827

Source DB:  PubMed          Journal:  Postepy Biochem        ISSN: 0032-5422


  4 in total

Review 1.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

Review 2.  P2Y1R and P2Y2R: potential molecular triggers in muscle regeneration.

Authors:  Min-Jia Wang; Bi-Ru Yang; Xin-Yu Jing; Yao-Zheng Wang; Lu Kang; Kai Ren; Liang Kang
Journal:  Purinergic Signal       Date:  2022-07-29       Impact factor: 3.950

3.  Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle.

Authors:  Rachel L Nosacka; Andrea E Delitto; Dan Delitto; Rohan Patel; Sarah M Judge; Jose G Trevino; Andrew R Judge
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-02-10       Impact factor: 12.910

Review 4.  Purine Nucleotides Metabolism and Signaling in Huntington's Disease: Search for a Target for Novel Therapies.

Authors:  Marta Tomczyk; Talita Glaser; Ewa M Slominska; Henning Ulrich; Ryszard T Smolenski
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.